Stem cells
| Zeile 15: | Zeile 15: | ||
{{tp|p=32387262|t=ä. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment |pdf=|usr=}} | {{tp|p=32387262|t=ä. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment |pdf=|usr=}} | ||
{{tp|p=C7163352|t=ä. Cell-Based Therapies for COVID-19: Proper Clinical Investigations are Essential |pdf=|usr=}} | {{tp|p=C7163352|t=ä. Cell-Based Therapies for COVID-19: Proper Clinical Investigations are Essential |pdf=|usr=}} | ||
| + | {{tp|p=32472653|t=2020. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.|pdf=|usr=007}} | ||
| + | |||
| + | |||
| + | |||
| + | {{tp|p=32479246|t=2020. Mesenchymal Stem Cell-based Therapy for COVID-19: Possibility and Potential.|pdf=|usr=007}} | ||
| + | {{tp|p=32380908|t=2020. Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.|pdf=|usr=007}} | ||
Version vom 23. Juni 2020, 14:02 Uhr
32292627 ä. Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic Influenza A (H7N9) infection, a hint for COVID-19 treatment
32265310 ä. Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19
32329380 2020. Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia
32296777 2020. Mesenchymal stem cells and management of COVID-19 pneumonia
32214286 2020. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use
32366290 2020. Mesenchymal stem cells as a potential therapy for COVID-19
32373992 2020. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment
32281052 ä. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future
32320535 2020. Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019
32371362 2020. Mesenchymal stem cell (MSc) secretome: A possible therapeutic strategy for intensive-care COVID-19 patients
32257554 2020. Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia
32257537 2020. Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
32283815 2020. Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use
32292113 2020. Stem Cell?Based Therapy for Coronavirus Disease 2019
32387262 ä. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment
C7163352 ä. Cell-Based Therapies for COVID-19: Proper Clinical Investigations are Essential
32472653 2020. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
32479246 2020. Mesenchymal Stem Cell-based Therapy for COVID-19: Possibility and Potential.
32380908 2020. Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.
